Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
39772 POSTS 0 COMMENTS
Lipid-lowering therapy with ezetimibe plus simvastatin is associated with improved clinical outcomes

Ezetimibe/Simvastatin Ups Clinical Outcomes in IMPROVE-IT

0
Reduction in total primary end point events, driven by reductions in myocardial infarction, stroke
Halaven (eribulin mesylate) has been approved by the U.S. Food and Drug Administration as the first chemotherapy drug shown to improve survival in people with advanced liposarcoma.

FDA Approves Halaven for Advanced Liposarcoma

0
FDA says it's first liposarcoma drug to improve survival
Even when blood tests of HIV patients on antiretroviral drugs show no sign of the virus

HIV Can Replicate in Lymphoid Tissue Despite ART Success

0
Findings in patients who had no detectable virus in their blood
Alginate derivatives have been generated that can overcome the challenge of foreign body response in the use of implanted medical devices

New Approach Described for Type 1 Diabetes

0
Studies assess ways to overcome challenge of foreign body response with alginate derivative
The top four issues that will be promoted in state legislation in 2016 were discussed at the 2016 American Medical Association (AMA) State Legislative Strategy Conference

AMA Highlights Top Four Issues to Promote in State Legislation

0
Issues include physician-led team-based care, improving patient health, reducing rx drug overdose
For warfarin-treated patients

Carbamazepine Affects Warfarin Anticoagulation

0
Carbamazepine co-treatment linked to subtherapeutic anticoagulative effect of warfarin
Video-assisted ablation of pilonidal sinus seems safe and efficacious

Minimally Invasive Surgery Safe for Pilonidal Sinus

0
Less time off work, higher patient satisfaction with video-assisted ablation of pilonidal sinus
Increased consumption of most flavonoid subclasses is inversely associated with weight change over time

Flavonol Intake May Contribute to Weight Maintenance

0
Increased consumption of most flavonoid subclasses inversely linked to weight change over time
For patients with John Cunningham virus (JCV)

Tysabri Impacts Seroconversion in John Cunningham Virus

0
Over 14.8 months, natalizumab treatment linked to 15.9 percent increase of value in JCV+ patients
Driving cessation in older adults is tied to a variety of health problems

Driving Cessation Tied to Adverse Effects on Health in Older Adults

0
Declines seen in general health and physical, social, and cognitive function